Work

Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia.

Year: 1994
Type: article
Abstract: The Philadelphia chromosome (Ph'), detected in virtually all cases of chronic myelogenous leukemia (CML), is formed by a reciprocal translocation between chromosome 9 and 22 that fuses Bcr-encoded sequences upstream of exon 2 of c-Abl.This oncogene produces a fusion protein, p210bcr-"b', in which the Ab1 tyrosine kinase activity is elevated.Using anti-phosphotyrosine immunoblotting, we have compared the pattern of phosphotyrosine-containing proteins from freshly prepared neutrophils of patients in the stable phase of CML to normal controls.The only consistent difference was the presence of a 39-kDa tyrosine-phosphorylated protein in 18 out of 18 neutrophil samples from CML patients that was not seen in normal controls.This same protein, as assessed by two-dimensional anti-phosphotyrosine immunoblotting, was also present in cell lines expressing p210b"""*', including K562 cells.Using K562 cells as a source of protein, the 39-kDa protein was purified and identified by microsequencing as Crkl, an SH2/SH3 adaptor protein related to the crk oncogene of the avian sarcoma virus, CT10.A direct interaction between Crkl and Ab1 has also been shown using a yeast two-hybrid screen.The p210bcr-"b' oncogene, present in virtually all cases of chronic myelogenous leukemia (CML),l is derived from a hybrid gene created by the Philadelphia chromosomal translocation (1-4).This hybrid gene has elevated protein tyrosine kinase activity and has been shown to cause a CML-like syndrome in mice (5, 6) and to transform immature hematopoietic cells in CA 36167 and 34183 (to J. D. G.) and CA 01422 (to B. J. D.).The costs
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,430
OpenAlex ID: W1484834653
FWCI: 6.438
Cites: 29
Cited by: 275
Related to: 10